Litigation Details for ARAGON PHARMACEUTICALS, INC. v. LUPIN LIMITED (D.N.J. 2022)
✉ Email this page to a colleague
ARAGON PHARMACEUTICALS, INC. v. LUPIN LIMITED (D.N.J. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-05-13 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-12-11 |
| Cause | 15:1126 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Parties | ARAGON PHARMACEUTICALS, INC. | ||
| Patents | 10,052,314; 9,481,663; 9,884,054 | ||
| Attorneys | JAMES S. RICHTER | ||
| Firms | Robinson Miller LLC, Ironside Newark | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ARAGON PHARMACEUTICALS, INC. v. LUPIN LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ARAGON PHARMACEUTICALS, INC. v. LUPIN LIMITED (D.N.J. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-08-05 | 24 | Amended Complaint | United States Patent Nos. 9,481,663 (“the 663 Patent”), 9,884,054 (“the 054 Patent”), 10,052,314 (“the 314…-cv-02964-JXN-LDW (663 Patent, 054 Patent, 314 Patent, 508 Patent, 888 Patent), Aragon Pharmaceuticals…cv- 03212-EP-LDW (663 Patent, 054 Patent, 314 Patent, 508 Patent, 888 Patent) and in the pending matters…1:22-cv-00696-CFC (663 Patent, 054 Patent, 314 Patent, 508 Patent, 888 Patent). Further, there are not…314 Patent”), 10,702,508 (“the 508 Patent”), and 10,849,888 (“the 888 Patent”) (collectively, the “Patents-In-Suit | External link to document |
| 2023-12-06 | 83 | Letter | Plaintiffs Claims of Infringement of U.S. Patent No. 9,481,663. (Attachments: # 1 Text of Proposed Order… 11 December 2023 2:22-cv-02825 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-12-11 | 84 | Judgment AND Stipulation and Order | PLAINTIFFS' CLAIMS OF INFRINGEMENT OF U.S. PATENT NO. 9,481,663. Signed by Judge Stanley R. Chesler on 12… INFRINGEMENT OF U.S. PATENT NO. 9,481,663 WHEREAS, Plaintiffs Aragon Pharmaceuticals… Count I of 5. patent against Defendants if Defendants have altered, … 11 December 2023 2:22-cv-02825 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
